Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 13,765-13,776 of 23,847
Drug study icon
CompletedNCT02695355

ERP Based Single-dose Predictions of Stimulants

This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

In Fredrikstad
ADHDDrugA study involving a medication or substance.From 8 Years to 17 Years
Countries
Norway
Sponsor
Ostfold Hospital Trust
Condition
ADHD
Other study type icon
Active Not RecruitingNCT06985381

ESAN III - Energy Sensing in Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Graz
DepressionOtherFrom 18 Years to 65 Years
Countries
Austria
Sponsor
Medical University of Graz
Condition
Depression
Drug study icon
CompletedNCT00116532

Escitalopram for OCD (OCD)

This summary needs review. Please check the official study record and contact the research team for details.

In Charlestown
OCDDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
OCD
Drug study icon
CompletedNCT00115011

Escitalopram for Self-Injurious Skin Picking

This summary needs review. Please check the official study record and contact the research team for details.

In Boston
OCDDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
OCD
Drug study icon
TerminatedNCT00464191

Escitalopram for depression in bipolarity

This study was terminated in Norway. It is testing escitalopram for depression in bipolarity.

In Nordfjordeid
Bipolarity, DepressionDrugFrom 18 Years to 70 Years
Countries
Norway
Sponsor
Nordfjord Psychiatric Centre
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00456937

Escitalopram in Schizophrenia in OCD- Open Label Study

This summary needs review. Please check the official study record and contact the research team for details.

In Beer Yaakov
Schizophrenia, OCDDrugFrom 18 Years to 65 Years
Countries
Israel
Sponsor
BeerYaakov Mental Health Center
Condition
Schizophrenia, OCD
Drug study icon
CompletedNCT00636649

Escitalopram Treatment of Night Eating Syndrome

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including St Louis
Eating disordersDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Duke University
Condition
Eating disorders
Drug study icon
CompletedNCT06624878

Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer

This study exists to learn from real-world information that can show how questionnaires and follow-up reports fits into care. Researchers are trying to understand whether questionnaires and follow-up reports can improve sleep, daily rhythms, and longer-term stability.

In Hangzhou
DepressionDrugFrom 18 Years to 80 Years
Countries
China
Sponsor
Zhejiang Cancer Hospital
Condition
Depression
Drug study icon
CompletedNCT06355180

Esketamine vs ECT for Acute Suicide prevention

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Wuhu
Suicidality, DepressionDrugFrom 18 Years to 65 Years
Countries
China
Sponsor
Capital Medical University
Condition
Suicidality, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.